Cardiac Anatomy and Conduction System: GPAT Pharmacology Guide

Introduction to Cardiac Anatomy in Pharmacy

Understanding the gross anatomy and cellular architecture of the human heart is essential for mastering cardiovascular pharmacology. From inotropic agents to antiarrhythmic drugs, therapeutic molecules exert their effects on specific anatomical structures, ion channels, and receptor populations. For students embarking on GPAT preparation or revising for NIPER and B.Pharm exams, cardiac anatomy serves as the foundation for predicting drug actions, adverse effects, and toxicities.

The heart is a muscular organ located in the middle mediastinum, enclosed within the pericardial sac. Its wall consists of three distinct layers:

• Epicardium: The outer visceral layer of the serous pericardium, containing coronary blood vessels, lymphatics, and fibroelastic tissue.
• Myocardium: The thick middle muscular layer composed of specialized cardiac muscle cells (cardiomyocytes) responsible for pumping blood. This layer contains rich networks of beta 1 adrenergic receptors and sodium potassium ATPase pumps.
• Endocardium: The inner endothelial lining that covers the heart valves and chambers, providing a smooth surface to prevent thrombosis.

Heart Chambers and Coronary Circulation

The human heart contains four chambers: the right atrium, right ventricle, left atrium, and left ventricle. Deoxygenated blood returns from systemic circulation via the superior and inferior vena cava into the right atrium. It traverses the tricuspid valve into the right ventricle, which propels blood through the pulmonary semilunar valve into the pulmonary arteries toward the lungs.

Oxygenated blood returns from the pulmonary veins into the left atrium, passes through the bicuspid (mitral) valve into the left ventricle, and is ejected through the aortic valve into the systemic circulation. The left ventricle has a myocardial wall approximately three times thicker than the right ventricle due to the higher resistance of the systemic vascular bed.

Coronary blood flow supplies the myocardium directly during ventricular diastole:

• Left Coronary Artery: Divides into the Left Anterior Descending (LAD) artery, which supplies the anterior wall of the ventricles and the interventricular septum, and the Circumflex artery, supplying the lateral left ventricular wall.
• Right Coronary Artery: Supplies the right atrium, right ventricle, and the inferoposterior parts of the left ventricle. Crucially, the right coronary artery supplies the Sinoatrial (SA) node in approximately 60 percent of individuals and the Atrioventricular (AV) node in 90 percent of individuals.

Pharmacological agents such as Nitroglycerin (sublingual dose 0.3 mg to 0.6 mg) relieve angina by inducing systemic venodilation to reduce preload, alongside dilating large epicardial coronary vessels to redistribute blood flow to ischemic myocardium.

The Cardiac Conduction System: Pacemakers and Pathways

Coordinated contraction of the heart depends upon specialized autorhythmic cells that generate and propagate electrical impulses without extrinsic nerve stimulation.

Sinoatrial (SA) Node

Located at the junction of the superior vena cava and the upper right atrium, the SA node functions as the primary physiological pacemaker of the heart. It exhibits an intrinsic firing rate of 60 to 100 impulses per minute. The action potential of SA nodal cells is distinct from working myocytes because it relies on spontaneous Phase 4 depolarization driven by funny currents (hyperpolarization activated cyclic nucleotide gated channels, or HCN channels) followed by calcium influx through T type and L type calcium channels.

Atrioventricular (AV) Node

Located within the triangle of Koch in the posteroinferior region of the interatrial septum, the AV node serves as the crucial gatekeeper between the atria and ventricles. It possesses an intrinsic firing rate of 40 to 60 impulses per minute. The AV node introduces an essential physiological delay of approximately 0.09 to 0.12 seconds in impulse transmission. This delay ensures that the atria complete their contraction and ventricular filling is maximized before ventricular systole occurs.

Bundle of His and Purkinje Fibers

The impulse travels from the AV node through the atrioventricular bundle of His, which splits into the right and left bundle branches along the interventricular septum. These branches terminate in extensive Purkinje fiber networks arborizing within the subendocardial myocardium. Purkinje fibers exhibit the fastest conduction velocity in the heart (2 to 4 meters per second) and an intrinsic firing rate of 20 to 40 impulses per minute.

Electrophysiology and Pharmacological Drug Targets

Cardiac electrophysiology directly dictates the Vaughan Williams antiarrhythmic drug classification, making it a critical component of any Pharmacology cheat sheet.

Ventricular Action Potential Phases

• Phase 0 (Rapid Depolarization): Driven by rapid influx of sodium ions via voltage gated Na+ channels. Target of Class I antiarrhythmics such as Procainamide, Lidocaine, and Flecainide.
• Phase 1 (Early Repolarization): Transient outward potassium current (Ito) and inactivation of fast sodium channels.
• Phase 2 (Plateau Phase): Influx of calcium ions through L type calcium channels balanced by efflux of potassium ions. Target of Class IV agents including Verapamil and Diltiazem.
• Phase 3 (Rapid Repolarization): Outward delayed rectifier potassium currents. Target of Class III antiarrhythmics including Amiodarone and Sotalol.
• Phase 4 (Resting Membrane Potential): Maintained near minus 90 mV by the inward rectifier potassium channel and sodium potassium ATPase.

Autonomic Receptors in Heart Tissue

The autonomic nervous system modulates cardiac rate, conduction velocity, and contractile force through targeted receptors:

• Beta 1 Adrenergic Receptors: Coupled to Gs proteins. Activation increases intracellular cyclic adenosine monophosphate (cAMP) and activates Protein Kinase A. This produces positive chronotropy (increased heart rate), positive inotropy (increased contractility), positive dromotropy (increased conduction velocity), and positive lusitropy (enhanced relaxation rate). Dobutamine selectively stimulates these receptors.
• Muscarinic M2 Receptors: Coupled to Gi proteins, activated by acetylcholine released from the vagus nerve. Activation reduces cAMP and opens G protein coupled inwardly rectifying potassium channels, hyperpolarizing nodal cells. This causes negative chronotropy and marked prolongation of AV nodal conduction time. Atropine (0.5 mg to 1 mg IV) competitively blocks M2 receptors to treat severe bradycardia.

High Yield Clinical Pharmacology Notes

• Ivabradine: Selectively blocks the funny current (If) in the SA node. Dose is usually 5 mg twice daily. It lowers heart rate without altering myocardial contractility or ventricular repolarization.
• Adenosine: Administered as a rapid IV bolus (6 mg initial dose, followed by 12 mg if uncorrected). It activates A1 adenosine receptors on the AV node, hyperpolarizing the tissue and producing transient AV block. It is the drug of choice for acute conversion of Paroxysmal Supraventricular Tachycardia (PSVT).
• Digoxin: Inhibits the myocardial sodium potassium ATPase pump, leading to increased intracellular calcium through the sodium calcium exchanger. Maintenance dose ranges from 0.125 mg to 0.25 mg daily. It increases contractile force while simultaneously slowing AV conduction through central vagal stimulation.

Exam Strategy for Pharmacy Students

When preparing Pharmacy study notes, always correlate anatomical structures with electrophysiological events and pharmacological interventions. In competitive testing environments, questions frequently test conduction speeds (fastest in Purkinje fibers, slowest in AV node) and the receptor populations located within specific chambers.

Summary

Cardiac anatomy integrates muscular chambers, coronary arteries, and a specialized electrical conduction system comprising the SA node, AV node, and Purkinje fibers. The unique electrophysiological properties of nodal and ventricular tissues provide distinct targets for antiarrhythmics, inotropes, and autonomic drugs. Mastering heart anatomy and receptor biology is an indispensable step toward excelling in national pharmacy licensure and postgraduate entrance tests.